(CIDRAP News) The US government has issued about $60 million in contracts to spur development of a vaccine against tularemia, the National Institutes of Health (NIH) announced recently.
The National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH, has issued two 5-year contracts for vaccine work, the agency said earlier this month. The agency also awarded $87 million in grants to build four biosafety level 3 (BSL-3) labs.